T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.48B |
| 2 |
Kenvue
KVUE
|
+$1.5B |
| 3 |
Halliburton
HAL
|
+$1.12B |
| 4 |
Boeing
BA
|
+$950M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$920M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.64B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.66B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.56B |
| 5 |
Amazon
AMZN
|
+$1.17B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 16.83% |
| 3 | Financials | 10.91% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Castle Biosciences
CSTL
$933M
| $279K | ﹤0.01% |
16,475
+1,009
| +7% | +$17.6K |
|
2352
GoPro
GPRO
$117M
| $279K | ﹤0.01% |
88,661
+11,799
| +15% | +$44.8K |
|
2353
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $279K | ﹤0.01% |
3,400
| – | – |
|
|
EARN
2354
Ellington Residential Mortgage REIT
EARN
$167M
| $277K | ﹤0.01% |
44,600
| – | – |
|
2355
iShares National Muni Bond ETF
MUB
$45.9B
| – | – |
0
| – | – |
|
2356
Liberty Live Group Series A
LLYVA
$9.59B
| $276K | ﹤0.01% |
+8,644
| New | +$284K |
|
2357
AMC Entertainment Holdings
AMC
$2.35B
| $275K | ﹤0.01% |
34,407
+4,922
| +17% | +$146K |
|
2358
Funko
FNKO
$335M
| $275K | ﹤0.01% |
35,942
+7,867
| +28% | +$58.6K |
|
2359
Usana Health Sciences
USNA
$252M
| $275K | ﹤0.01% |
4,688
+332
| +8% | +$20.8K |
|
2360
Vertex
VERX
$2.15B
| $275K | ﹤0.01% |
11,849
-43,068
| -78% | -$886K |
|
2361
4D Molecular Therapeutics
FDMT
$609M
| $274K | ﹤0.01% |
21,490
+2,570
| +14% | +$43K |
|
2362
James River Group Holdings
JRVR
$200M
| $274K | ﹤0.01% |
17,788
+2,842
| +19% | +$46.3K |
|
2363
Oric Pharmaceuticals
ORIC
$1.42B
| $274K | ﹤0.01% |
45,115
-17,949
| -28% | -$147K |
|
|
ALEX
2364
DELISTED
Alexander & Baldwin
ALEX
| $273K | ﹤0.01% |
16,311
+1,707
| +12% | +$30.9K |
|
2365
Artesian Resources
ARTNA
$369M
| $272K | ﹤0.01% |
6,474
-3,450
| -35% | -$159K |
|
2366
Hurco Companies Inc
HURC
$143M
| $272K | ﹤0.01% |
12,100
| – | – |
|
2367
VSE Corp
VSEC
$6.48B
| $271K | ﹤0.01% |
5,372
+740
| +16% | +$40.2K |
|
2368
Comtech Telecommunications
CMTL
$52.7M
| $270K | ﹤0.01% |
30,800
+580
| +2% | +$5.41K |
|
2369
Mesa Laboratories
MLAB
$633M
| $270K | ﹤0.01% |
2,562
+117
| +5% | +$15K |
|
2370
Peapack-Gladstone Financial
PGC
$822M
| $270K | ﹤0.01% |
10,520
+479
| +5% | +$13.3K |
|
2371
Domo
DOMO
$187M
| $269K | ﹤0.01% |
27,393
+3,483
| +15% | +$48.4K |
|
2372
Turning Point Brands
TPB
$1.73B
| $269K | ﹤0.01% |
+11,628
| New | +$283K |
|
2373
Grid Dynamics Holdings
GDYN
$644M
| $268K | ﹤0.01% |
21,934
+1,704
| +8% | +$18.9K |
|
2374
Orion
OEC
$360M
| $268K | ﹤0.01% |
12,592
+1,230
| +11% | +$26.8K |
|
2375
Aldeyra Therapeutics
ALDX
$86.9M
| $267K | ﹤0.01% |
39,892
+742
| +2% | +$5.5K |
|
Similar funds
T. Rowe Price Associates's Q3 2023 Portfolio in Review
As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
- T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
- T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
- T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
- T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
- T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.
Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.